DMAG, a novel countermeasure for the treatment of thrombocytopenia

BACKGROUND: Thrombocytopenia is one of the most common hematological disease that can be life-threatening caused by bleeding complications. However, the treatment options for thrombocytopenia remain limited. METHODS: In this study, giemsa staining, phalloidin staining, immunofluorescence and flow cy...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Jing, Zeng, Jing, Liu, Sha, Shen, Xin, Jiang, Nan, Wu, Yue-Song, Li, Hong, Wang, Long, Wu, Jian-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626956/
https://www.ncbi.nlm.nih.gov/pubmed/34837956
http://dx.doi.org/10.1186/s10020-021-00404-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626956/
https://www.ncbi.nlm.nih.gov/pubmed/34837956
http://dx.doi.org/10.1186/s10020-021-00404-1

Ejemplares similares